ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2004
Antidepressants and adverse effects in young patients: uncovering the evidence.
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.International journal of obesity (2005) · 2016Article
- Understanding Users in the 'Field' of Medications.Pharmacy (Basel, Switzerland) · 2016Article
- Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization.Frontiers in public health · 2015Article
- Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2012Article
- What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.BMC clinical pharmacology · 2011Article
- SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent · 2011Article
- Antidepressants and Suicide Risk: A Comprehensive Overview.Pharmaceuticals (Basel, Switzerland) · 2010Review
- Review
- Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.Drug safety · 2009Article
- Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.British journal of clinical pharmacology · 2007Review
- Manufacturing consensus.Culture, medicine and psychiatry · 2006Article
- Sikh birth customs.Archives of disease in childhood · 2005Review
- Should paediatricians support the European Paediatric Clinical Trials Register?Archives of disease in childhood · 2005Review
- SSRI treatment for under-18s.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2004Article
- Efficacy and safety of antidepressants for children and adolescents.BMJ (Clinical research ed.) · 2004Review
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
14970096PMC332715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.